AMICUS THERAPEUTICS, INC. — Director's Dealing 2016

Feb 16, 2016

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-12-31

Reporting Person: Crowley John F (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-30	Common Stock	A	25088	$13.75	Acquired	121780	Direct
2015-12-23	Common Stock	G	25088	$0.00	Disposed	96692	Direct
2015-12-23	Common Stock	G	10000	$0.00	Disposed	86692	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	64895	Indirect

Footnotes

F1: Mr. Crowley acquired 25,088 shares of common stock on September 30, 2015 in connection with Amicus Therapeutics, Inc.'s acquisition of Scioderm, Inc.

F2: Mr. Crowley donated 25,088 shares to various 501(c)(3) charities for the benefit of children with Epidermolysis Bullosa (EB) rare disease.

F3: Mr. Crowley donated 10,000 shares to the Make-A-Wish Foundation of America.